Emergent BioSolutions to cut 300 employees, shutter 2 facilities in restructuring launched under new CEO aliu Wed, 05/01/2024 - 16:31

WuXi Biologics withdraws from 2024 BIO convention amid worsening geopolitical tensions fkansteiner Tue, 04/30/2024 - 15:54

GSK's Arexvy maintains its RSV market dominance, looks to key label expansion as Moderna's mRNA threat looms zbecker Wed, 05/01/2024 - 11:34

Pfizer sets up DTC marketing platform as Q1 sales beat expectations kdunleavy Wed, 05/01/2024 - 11:31

J&J subsidiary floats $6.48B settlement to resolve thousands of claims that its talc products caused ovarian cancer fkansteiner Wed, 05/01/2024 - 10:34

BIO survey to elucidate US biopharma's reliance on Chinese CDMOs amid decoupling threats aliu Wed, 05/01/2024 - 10:28